Target intelligence / Profile preview

MicroRNA 520c (miR-520c)

Target
miR-520c
Molecular classification
MicroRNA (miRNA), Non-coding RNA, Part of the miR-520/373 family
01

Overview

MicroRNA 520c is a small, non-coding RNA of 22 nucleotides, part of a large microRNA cluster on human chromosome 19. It exerts post-transcriptional regulation of gene expression and displays context-dependent biological activities: acting as a tumor suppressor in some cancers (e.g., estrogen receptor-negative breast cancer) by inhibiting NF-κB and TGF-β pathways, and as an oncogene in hepatitis B virus-related hepatocellular carcinoma, where it is upregulated and promotes malignant progression by suppressing PTEN and activating AKT/NF-κB signaling. Its expression levels are associated with disease severity and patient prognosis, indicating its value as a diagnostic and therapeutic target, although conflicting effects in different cancers highlight the complexity of miRNA biology.

Other names
hsa-mir-520cMIR520CMIRN520Chsa-mir-520c-3phsa-mir-520c-5p
02

Mechanism of action

Antagomir inhibition of miR-520c-3p reduces its regulatory activity, potentially restoring expression of tumor suppressors like PTEN in hepatocellular carcinoma. General approach: synthetic miRNA mimics or inhibitors modulate the activity of endogenous miRNAs.

03

Biological functions

Regulation of gene expressionModulation of epithelial-mesenchymal transition (EMT)Regulation of cell proliferationInhibition or promotion of cell migration and invasion (context-dependent)Modulation of immune response and inflammation via NF-κB signalingApoptosis (context-dependent)Influences cancer progression and metastasis
04

Disease associations

Cancer (including hepatocellular carcinoma, breast cancer, lung cancer)InflammationInfection (notably related to hepatitis B virus-induced hepatocellular carcinoma)May be relevant in other diseases where dysregulated miRNA expression plays a role
05

Safety considerations

Off-target effects due to the non-specific nature of miRNA bindingPossible impacts on non-cancerous tissues where miR-520c has physiological rolesParadoxical roles: miR-520c may act as either an oncogene or tumor suppressor depending on cellular context, raising concerns for therapeutic targeting
06

Interacting drugs

No specific drugs directly targeting miR-520c are FDA-approved or named in the provided sources; however, antagomirs (synthetic oligonucleotides) designed against miR-520c-3p have been used experimentally to inhibit its function
07

Biomarkers

miR-520c-3p expression level is proposed as a biomarker for prognosis in hepatocellular carcinoma, especially HBV-related casesIts expression may also serve as a marker for breast cancer metastasis risk in estrogen receptor-negative tumors

Beyond the preview

Go deeper on MicroRNA 520c (miR-520c).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 520c (miR-520c).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call